"Corporate profile" An English version and a Japanese version are updated.
Presentation Material (Third Quarter Financial Results for FY2014)
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2015
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2015 [Japanese GAAP] (Unaudited)
Sumitomo Dainippon Pharma Announces Collaboration on Lurasidone, an Atypical Antipsychotic Agent, for Thailand, Singapore and Hong Kong
Sunovion Pharmaceuticals Inc. Files Patent Infringement Lawsuits Regarding Latuda
A Message from the President
Board of Directors and Executive Officers